• Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws and American Association of Oral and Maxillofacial Surgeons (2007) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. Journal of Oral and Maxillofacial Surgery, 65, 369376.
  • Assael, L.A. (2009) Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. Journal of Oral and Maxillofacial Surgery, 67, 3543.
  • Benlidayi, C. & Guzel, R. (2013) Oral bisphosphonate related osteonecrosis of the jaw: a challenging adverse effect. ISRN Rheumatology, 2013, 215034215040.
  • Chatterjee, R., Shah, F.S., Davis, B.A., Byers, M., Sooranna, S., Bajoria, R., Pringle, J. & Porter, J.B. (2012) Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome. British Journal of Haematology, 159, 462471.
  • Fedele, S., Porter, S.R., D'Aiuto, F., Aljohani, S., Vescovi, P., Manfredi, M., Arduino, P.G., Broccoletti, R., Musciotto, A., Di Fede, O., Lazarovici, T.S., Campisi, G. & Yarom, N. (2010) Non exposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. American Journal of Medicine, 123, 10601064.
  • Koka, S., Clarke, B.L., Amin, S., Gertz, M. & Ruggiero, S.L. (2007) Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient. The International Journal of Prosthodontics, 20, 115122.
  • Kühl, S., Walter, C., Acham, S., Pfeffer, R. & Lambrecht, J.T. (2012) Bisphosphonate-related osteonecrosis of the jaws–a review. Oral Oncology, 48, 938947.
  • Marx, R.E. (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of Oral and Maxillofacial Surgery, 61, 11151117.
  • Otto, S., Schreyer, C., Hafner, S., Mast, G., Ehrenfeld, M., Stürzenbaum, S. & Pautke, C. (2012) Bisphosphonate-related osteonecrosis of the jaws - characteristics, risk factors, clinical features, localization and impact on oncological treatment. Journal of Cranio-Maxillo-Facial Surgery, 40, 303309.
  • Terpos, E. & Voskaridou, E. (2010) Treatment options for thalassemia patients with osteoporosis. Annals of the New York Academy of Sciences, 1202, 237243.